Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
Healthy Volunteers
NCT06075134

EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients

Led by Cairo University · Updated on 2026-03-20

32

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the effect of EMG-guided Botox injection with conventional Botox injection in Yonsei point, in patients with excessive gingival display. The main question it aims to answer is: • Does the use of electromyography (EMG) as a guide during Botox injection for patients with gummy smile has better effect than conventional injection in Yonsei point? Participants will be randomized in equal proportions between intervention and control groups. * Preoperative assessment of amount of gingival display, lip length (philtrum and vermilion length), and smile type. * For the intervention group, EMG readings will be done in Clinical Neurophysiology Department, Kasr Al-Ainy Hospital EMG-guided Botox injection (Intervention group). Conventional Botox injection in Yonsei point (Control group).

CONDITIONS

Official Title

EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients

Who Can Participate

Age: 18Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with excessive gingival display
  • Patients with esthetic concerns
  • Patients with mild to moderate vertical maxillary excess (VME)
  • Normal clinical crown dimensions
  • Patients aged 18 to 50
  • Systemically healthy patients
  • Non-smokers
Not Eligible

You will not qualify if you...

  • Patients with severe vertical maxillary excess (VME)
  • Pregnant and breastfeeding women
  • Patients with gingival inflammation and/or enlargement
  • Inflammation or infection at the site of injection
  • Patients allergic to any Botox components (saline, human albumin, lactose, sodium succinate)
  • Patients using anticholinesterase or agents affecting neuromuscular transmission
  • Psychologically unstable patients or those with unrealistic expectations
  • Patients with neuromuscular disorders (e.g., myasthenia gravis, Eaton-Lambert syndrome)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Faculty of Dentistry, Cairo University

Cairo, Egypt

Actively Recruiting

Loading map...

Research Team

S

Sherry Fayez Akhnokh, BSc

CONTACT

N

Nesma Shemais, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here